Is pre-clinical pharmacological safety testing important in your work? Watch this webinar to learn how fluorescence-based kinetic scanning can offer greater speed, reproducibility, and robustness to your safety pharmacology assays.

This seminar features an automated optical plate reader, Lumencor’s VOLTA Scanner, for safety pharmacology testing. Proarrhythmic risk is assessed using the Comprehensive in Vitro Proarrhythmia Assay (CiPA) library to evaluate test compounds in cardiac ion-channel assays. The VOLTA offers both precision and speed in what historically is an arduous, technically challenging electrophysiology analysis. The meeting is hosted by DDN, and features talks by esteemed industry leaders, Dr. Nick Radio, Global Sales Manager - Strategic Accounts, Lumencor, Inc., and Dr. Steve Jenkinson, VP of Drug Discovery & Safety Assessment, Metrion Biosciences.